Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Nuria Chic"'
Autor:
Yaroslav Shparyk, Andrew D. Seidman, Yee Soo Chae, Lee S. Schwartzberg, Thomas Wei, Yevhen Hotko, Yen-Shen Lu, Sina Vatandoust, Sara M. Tolaney, Noshir Anthony Dacosta, Sabela Recalde, Chi-Feng Chung, Igor Bondarenko, Hope S. Rugo, Nuria Chic, Patricia Gomez, Joyce O'Shaughnessy, Joe O'Connell, Lawrence Panasci, Gail Lynn Shaw Wright
Publikováno v:
Journal of Clinical Oncology. 39:1061-1061
1061 Research Funding: Odonate Therapeutics, Inc. Background: T is a novel, oral taxane with unique properties, including: oral administration with a low pill burden, a long (8-day) half-life in humans, once-every-3-weeks dosing, no observed hypersen
Autor:
Marta Amérigo Góngora, Nuria Ribelles, Maria Carmen Álamo de la Gala, Martina Alvarez, Aleix Prat, José M. Jerez, T. Pascual, Aurora Laborda Illanez, Rocío Lavado-Valenzuela, Luis Vicioso, Javier Pascual, Emilio Alba, Cristina Morales-Estevez, Fernando Galvez Montosa, Alejandro Falcon, Tamara Diaz-Redondo, Aranzazu Fernandez, Begona Jimenez Rodriguez, Nuria Chic, Macarena González Guerrero
Publikováno v:
Journal of Clinical Oncology. 36:e12634-e12634
e12634Background: We aim to compare the benefit of adding pertuzumab (P) to the standard neoadjuvant treatment with trastuzumab (T) in patients (pt) with early immunohistochemically (IHC) defined H...
Autor:
Maria Verónica Pereira, Maria Mila, Natalia Jiménez, Maria Coral Pérez-Gago, Nuria Chic, Iván Victoria, Mercedes Marín-Aguilera, Begoña Mellado, Òscar Reig
Publikováno v:
Journal of Clinical Oncology. 36:254-254
254 Background: The constitutively active androgen receptor (AR) variant 7 (ARV7) has been associated to AR inhibitors resistance, but its role in taxane-benefit has not been stablished. Moreover, the neutrophil-to-lymphocyte ratio (NLR) has been ass
Autor:
Francisco Aya, Nuria Chic, Laureano Molins, Nuria Viñolas, José Ramírez, Alfons Navarro, Aranzazu Fernandez, Anna Cordeiro, Ramon M. Marrades, Mariano Monzo, Josep Maria Gimferrer
Publikováno v:
Journal of Clinical Oncology. 33:11043-11043
11043 Background: Piwi-RNAs (piRNAs) are small non-coding RNAs (24-32 nt) required to protect the genome in germline cells. Initially they were thought to be expressed only in germline cells, but t...